文献速递乳腺癌

RBM38表达与乳腺癌远处转移及预后的关系

[Relationship between expression of RBM38 and distant metastasis and prognosis of breast cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2018-01-01

该研究纳入161例乳腺癌组织,用免疫组化SP法检测RBM38表达,分析其与远处转移和预后的关系。结果显示RBM38高表达组远处转移率更低、生存率更高,多因素Cox回归提示RBM38高表达是远处转移的独立保护因素。

要点

  • RBM38高表达组远处转移率显著低于低表达组(P=0.010)。
  • RBM38高表达组生存率显著高于低表达组(P=0.009)。
  • RBM38高表达是乳腺癌远处转移的独立保护因素(RR=0.328,95%CI 0.128~0.839)。

核心结论

  • RBM38高表达的乳腺癌患者远处转移率较低、预后较好。
  • RBM38高表达是乳腺癌患者发生远处转移的独立保护因素。

研究设计与样本

  • 选取161例乳腺癌患者,采用免疫组化SP法检测乳腺癌组织中RBM38蛋白表达水平。
  • 分析RBM38表达与远处转移及预后的关系,并用Cox回归模型分析远处转移的影响因素。

主要发现

  • 161例中RBM38高表达85例、低表达76例。
  • RBM38高表达组远处转移率显著低于低表达组(P=0.010),生存率显著高于低表达组(P=0.009)。
  • 单因素Cox回归显示病理分期(P=0.001)、腋窝淋巴结阳性(P=0.001)、RBM38表达水平(P=0.015)与远处转移有关。
  • 多因素Cox回归显示腋窝淋巴结阳性是远处转移的独立危险因素(RR=4.222,95%CI 1.235~14.432)。

关键数值与推荐

  • RBM38高表达为远处转移的独立保护因素(RR=0.328,95%CI 0.128~0.839)。
  • 腋窝淋巴结阳性为远处转移的独立危险因素(RR=4.222,95%CI 1.235~14.432)。

临床怎么用

  • 乳腺癌组织中RBM38高表达提示远处转移风险较低、预后较好,可作为预后评估的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the relationship between the expression of RNA-binding protein 38 (RBM38) and distant metastasis and prognosis of breast cancer. Methods: A total of 161 cases of breast cancer tissues were selected, and the expression of RBM38 was detected by immunohistochemical SP method. The relationship between the expression of RBM38 and the distant metastasis and prognosis of breast cancer patients were analyzed. Cox regression model was applied to analyze the influence factors of distant metastasis of breast cancer. Results: Among the 161 breast cancer patients, high expression of RBM38 was observed in 85 cases and low expression was observed in 76 cases. Log rank test showed that the distant metastasis rate of RBM38 highly expressed group was significantly lower than that of RBM38 lowly expressed group (P=0.010), while the survival rate was significantly higher (P=0.009). Univariate Cox regression analysis showed that the pathological stage (P=0.001), axillary lymph node positive (P=0.001), and the expression of RBM38 (P=0.015) were dramatically related to the distant metastasis of breast cancer patients. Multivariate Cox regression analysis showed that positive axillary lymph node was an independent risk factor (RR=4.222, 95% CI: 1.235-14.432), and high expression of RBM38 was an independent protective factor (RR=0.328, 95% CI: 0.128-0.839) of distant metastasis of breast cancer patients. Conclusion: High expression of RBM38 is positively related with low distant metastasis rate and good prognosis of breast cancer patients. Hence, high expression of RBM38 is an independent protective factor of distant metastasis. 目的: 探讨RNA结合蛋白38(RBM38)在乳腺癌组织中的表达及其与乳腺癌远处结转移和患者预后的关系。 方法: 选取161例乳腺癌患者,采用免疫组化SP法检测乳腺癌组织中RBM38蛋白的表达水平,分析RBM38蛋白的表达水平与乳腺癌远处结转移和患者预后的关系,采用Cox回归模型分析乳腺癌发生远处转移的影响因素。 结果: 161例患者中,RBM38蛋白高表达者85例,低表达者76例。log rank检验显示,与RBM38蛋白低表达组比较,RBM38蛋白高表达组远处转移率低,生存率高,差异均有统计学意义(P值分别为0.010和0.009)。单因素Cox回归分析结果显示,病理分期(P=0.001)、腋窝淋巴结阳性(P=0.001)、RBM38表达水平(P=0.015)与远处转移有关。多因素Cox回归分析结果显示,腋窝淋巴结阳性为乳腺癌患者发生远处转移的独立危险因素(RR=4.222, 95%CI为1.235~14.432),而RBM38蛋白高表达为乳腺癌患者发生远处转移的独立保护因素(RR=0.328, 95%CI为0.128~0.839)。 结论: RBM38高表达的乳腺癌患者远处转移率较低,预后较好。RBM38高表达是乳腺癌患者发生远处转移的独立保护因素。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhu L, Sun X, Xi PW, et al. [Relationship between expression of RBM38 and distant metastasis and prognosis of breast cancer]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30139030. doi:10.3760/cma.j.issn.0253-3766.2018.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。